News
Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...
6d
Daily Express US on MSNPfizer's Covid-19 vaccine availability for children under 5 faces potential FDA roadblock
The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?
As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...
11don MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
A third dose of the Pfizer COVID-19 vaccine can "strongly" boost protection against the delta variant, suggests new data released by Pfizer.
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
9d
Scripps News on MSNFDA signals it may revoke approval of Pfizer's pediatric COVID vaccine, leaving kids fewer options
The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...
The American Academy of Pediatrics released its updated recommendations for vaccines on Tuesday, including Covid-19 shots for ...
The Canadian Press on MSN1d
Health Canada approves updated Pfizer, Moderna COVID-19 vaccines for fall
TORONTO — Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this ...
Pfizer earlier this year signed a $1.9 billion pact to provide the U.S. government with 100 million doses of a COVID-19 vaccine. Americans would receive the vaccine for free, the pharmaceutical ...
Pfizer said Wednesday that a final assessment of trial data on the COVID-19 vaccine it developed in conjunction with German company BioNTech showed it was 95% effective, and that it would apply ...
A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri, U.S. in an undated photograph.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results